Diabetic Retinopathy Care at Retina Consultants
Schedule Today
Advanced Diagnostic Technology
We use state-of-the-art imaging to detect subtle changes early, map ischemia, and tailor treatment precisely over time.
Dilating the pupils allows a detailed view of the retina to detect microaneurysms, hemorrhages, ischemia, intraretinal microvascular abnormalities, and neovascularization. This painless exam remains foundational for diagnosis and staging.
OCT provides cross-sectional images that quantify retinal thickness, fluid, and tractional changes and guides treatment timing and response.
OCT-A noninvasively maps retinal and choroidal flow, highlighting capillary nonperfusion and neovascular complexes. It complements but does not replace fluorescein angiography when dynamic leakage assessment is needed.
Injected dye outlines areas of leakage, ischemia, and neovascularization, helping determine where laser or pharmacologic therapy is most beneficial.
Widefield color and angiographic imaging capture the peripheral retina to reveal nonperfusion and neovascularization that may change the treatment plan and laser distribution.
Serial high-quality photographs document disease severity and response, enabling clear communication with your other healthcare providers over time.
Comprehensive Treatment Options
Care is personalized to disease severity and visual needs, combining medications, laser, and surgery as appropriate with close monitoring of response.
Anti-VEGF medications are first-line for center-involved diabetic macular edema with reduced vision and are effective for proliferative disease when adherence to frequent visits is feasible. Newer options, including faricimab and higher-dose aflibercept, allow extended intervals in many responsive patients.
Dexamethasone and fluocinolone acetonide implants are established options for chronic or anti-VEGF-insufficient macular edema, particularly in pseudophakic patients, with careful monitoring for intraocular pressure rise and cataract.
PRP is standard therapy for proliferative retinopathy, reducing ischemic drive and bleeding risk; it may be considered in select severe NPDR cases when follow-up is uncertain or high-risk features are present. In patients at risk for loss to follow-up, durable PRP is often preferred over injection-only strategies.
Focal/grid laser is best suited for non-center-involved edema or persistent focal leaks despite pharmacotherapy. For center-involved edema, laser is typically adjunctive after pharmacologic treatment.
Vitrectomy is used for non-clearing vitreous hemorrhage, tractional retinal detachment threatening the macula, macular traction, or to permit PRP when the view is obscured. Surgery aims to remove blood and scar tissue, relieve traction, and stabilize or restore vision.
Therapies are often combined, such as anti-VEGF for edema with PRP for proliferative changes, with adjustments based on imaging and clinical response over time.
Long-acting steroid implants provide extended control for chronic edema, reducing visit burden in appropriate candidates. Other sustained-delivery approaches may be available depending on suitability and local availability.
Emergency Care and Urgent Symptoms
Some complications require immediate attention to prevent permanent vision loss and should be assessed urgently by a retina specialist.
Sudden severe vision loss, a shower of new floaters, flashing lights, a dark curtain, or severe eye pain can indicate bleeding, detachment, or dangerous pressure elevation and need urgent evaluation.
Bleeding into the vitreous can cause sudden haze and numerous floaters; prompt management shortens recovery and determines whether injections, laser, or surgery is needed to clear the blood and treat the source.
Scar tissue can pull the retina off the eye wall, threatening central vision and requiring surgical repair to reattach the retina and protect remaining sight.
New vessels in the eye’s drainage angle can raise eye pressure and threaten vision; early stages may be minimally symptomatic, but it can cause severe pain and requires urgent treatment.
We provide 24-hour emergency coverage; call our main number for instructions to reach the on-call physician if concerning symptoms arise outside business hours.
Living Successfully with Diabetic Retinopathy
With consistent eye care, optimized systemic control, and practical adaptations, most people maintain useful vision and independence over the long term.
Low-vision specialists offer training and devices that help maintain independence at home and work, complementing ongoing retina care to preserve function.
Night vision, contrast sensitivity, and central acuity changes may impact driving; we provide individualized guidance and reassessment after treatment.
Task lighting, high-contrast markings, larger displays, and accessible print sizes can improve performance of daily activities and reduce visual strain.
Including family in education improves adherence to glucose targets and follow-up, helping detect symptoms early and support treatment plans.
Adjusting to vision changes can be stressful; counseling and peer resources provide strategies to manage anxiety and maintain quality of life.
Magnifiers, screen readers, contrast settings, and smartphone accessibility apps can meaningfully improve daily function when paired with regular follow-up.
Safe, regular activity improves insulin sensitivity, blood pressure, and lipids; we can advise suitable options based on your eye status and treatments.
Coordinated Care with Your Medical Team
Retinal outcomes improve when eye care is aligned with diabetes management, blood pressure control, and lipid therapy through close collaboration.
We share retinal findings with your primary care and endocrinology teams to guide adjustments in systemic therapy and coordinate follow-up timing.
Keeping glucose near individualized targets slows retinopathy; we recommend closer eye monitoring during periods of rapid glycemic improvement.
Tight blood pressure control independently reduces progression risk, and lipid management lowers the likelihood of hard exudates and edema.
We review treatments including thiazolidinediones and GLP-1 receptor agonists in the context of ocular status, coordinating with your clinicians to optimize safety while supporting evidence-based systemic therapy.
Pre-existing diabetes and retinopathy warrant a preconception exam when possible and more frequent exams during pregnancy and postpartum to detect progression.
Tracking HbA1c, blood pressure, kidney status, and lipids informs eye risk and supports shared targets that reduce progression and treatment burden.
Prevention and Risk Reduction Strategies
While not all cases are preventable, comprehensive risk-factor control and scheduled eye exams substantially reduce the chance of vision-threatening complications.
Meeting individualized HbA1c goals with medication adherence, nutrition, and monitoring lowers risk and slows progression, with closer eye follow-up during intensive changes.
Staying within target ranges complements eye-directed therapies and reduces microvascular stress on retinal capillaries.
A diabetes-friendly diet supports glucose control, and adequate omega-3 intake may offer additional retinal benefits; lipid management reduces hard exudates and edema risk.
Avoiding tobacco improves vascular health throughout the body, including the retina, and aligns with long-term diabetes care goals.
Routine physical activity improves glycemic control, blood pressure, and lipids, directly benefiting ocular outcomes in diabetes.
Reducing chronic stress supports glucose stability and adherence to appointments and therapies, benefiting both overall health and vision.
Type 1 diabetes typically needs a first dilated exam within five years of diagnosis or at puberty (whichever is later), type 2 at diagnosis, then at least annually or every 1–2 years if no retinopathy and control is good.
Advanced Treatment Technologies
We continually adopt validated imaging and treatment advances to improve safety, precision, and access to high-quality care.
Modern imaging and laser systems enable precise assessment and targeted treatment planning tailored to your retinal findings.
Image-guided planning supports accurate placement for focal and panretinal laser in appropriate cases, improving efficiency and consistency of care.
AI-assisted image analysis enhances screening and triage by highlighting severity and peripheral lesions but does not replace comprehensive dilated exams.
Validated retinal photography workflows expand access where travel is difficult and help prioritize in-person visits; home-based tools are selected case-by-case.
Eligible patients may access investigational diagnostics or therapies through clinical research; availability and suitability are individualized.
Durable anti-VEGF regimens and established steroid implants can reduce visit frequency in appropriate candidates while maintaining close safety monitoring.
Insurance and Financial Information
We accept most major insurance plans and work with patients to make retinal care accessible and affordable, explaining coverage and costs up front.
Most treatments for diabetic retinopathy are covered by health insurance, including Medicare and Medicaid; we verify benefits and outline any expected costs before treatment.
When required, our team manages prior authorizations and works with your insurer to expedite approval for necessary therapies.
Flexible payment arrangements are available for uncovered services or cost-sharing, with financial counselors to help fit care into your budget.
We participate with Medicare and can explain coverage details and how supplemental plans may help with retinal treatment costs.
Frequently Asked Questions
Here are clear answers to common questions about prevention, monitoring, and treatment choices for diabetic retinopathy.
No, but meeting glucose, blood pressure, and lipid goals plus scheduled dilated exams can delay onset, reduce progression, and prevent many vision-threatening complications.
Most people do not go blind; early detection and appropriate therapy often stabilize or improve vision, though advanced damage may be permanent.
Type 1 generally within five years of diagnosis or at puberty (whichever is later), type 2 at diagnosis, then annually or every 1–2 years if no retinopathy and control is good; more often if retinopathy is present or worsening.
Numbing drops and, when needed, additional anesthesia make injections typically well tolerated; mild pressure is common, significant pain is uncommon.
Durability varies by eye and agent; some patients need monthly treatments while others extend to several months between visits based on response and imaging.
Dilation and transient blur can affect vision; many patients can drive the next day, and arranging a driver for the first visit helps assess individual tolerance.
Most diabetes medications do not interfere with ocular therapy; we coordinate with your clinicians, especially during rapid HbA1c changes, and review any agents associated with edema.
Yes. With coordinated glucose management and modern surgical care, retinal procedures are performed safely and aim to protect or restore vision.
Schedule Your Consultation
Early detection and personalized treatment are key to preserving sight, contact our Ridgewood, Belleville, or Jersey City offices to schedule your comprehensive consultation.